295 related articles for article (PubMed ID: 32933189)
21. Sphingosine-1-phosphate receptor 1 mediates elevated IL-6 signaling to promote chronic inflammation and multitissue damage in sickle cell disease.
Zhao S; Adebiyi MG; Zhang Y; Couturier JP; Fan X; Zhang H; Kellems RE; Lewis DE; Xia Y
FASEB J; 2018 May; 32(5):2855-2865. PubMed ID: 29401601
[TBL] [Abstract][Full Text] [Related]
22. S1P Signaling in the Tumor Microenvironment.
Schneider G
Adv Exp Med Biol; 2020; 1223():129-153. PubMed ID: 32030688
[TBL] [Abstract][Full Text] [Related]
23. Sphingosine kinase 1/sphingosine 1-phosphate/sphingosine 1-phosphate receptor 1 pathway: A novel target of geniposide to inhibit angiogenesis.
Sun M; Deng R; Wang Y; Wu H; Zhang Z; Bu Y; Zhang H
Life Sci; 2020 Sep; 256():117988. PubMed ID: 32569777
[TBL] [Abstract][Full Text] [Related]
24. Autocrine and paracrine roles of sphingosine-1-phosphate.
Alvarez SE; Milstien S; Spiegel S
Trends Endocrinol Metab; 2007 Oct; 18(8):300-7. PubMed ID: 17904858
[TBL] [Abstract][Full Text] [Related]
25. Downregulation of S1P Lyase Improves Barrier Function in Human Cerebral Microvascular Endothelial Cells Following an Inflammatory Challenge.
Stepanovska B; Lange AI; Schwalm S; Pfeilschifter J; Coldewey SM; Huwiler A
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32069843
[TBL] [Abstract][Full Text] [Related]
26. High endothelial venule blood vessels for tumor-infiltrating lymphocytes are associated with lymphotoxin β-producing dendritic cells in human breast cancer.
Martinet L; Filleron T; Le Guellec S; Rochaix P; Garrido I; Girard JP
J Immunol; 2013 Aug; 191(4):2001-8. PubMed ID: 23825314
[TBL] [Abstract][Full Text] [Related]
27. Metastatic triple-negative breast cancer is dependent on SphKs/S1P signaling for growth and survival.
Maiti A; Takabe K; Hait NC
Cell Signal; 2017 Apr; 32():85-92. PubMed ID: 28108260
[TBL] [Abstract][Full Text] [Related]
28. Prognostic Implications of Heterogeneity in Intra-tumoral Immune Composition for Recurrence in Early Stage Lung Cancer.
Mony JT; Schuchert MJ
Front Immunol; 2018; 9():2298. PubMed ID: 30374348
[No Abstract] [Full Text] [Related]
29. A subset of activated fibroblasts is associated with distant relapse in early luminal breast cancer.
Bonneau C; Eliès A; Kieffer Y; Bourachot B; Ladoire S; Pelon F; Hequet D; Guinebretière JM; Blanchet C; Vincent-Salomon A; Rouzier R; Mechta-Grigoriou F
Breast Cancer Res; 2020 Jul; 22(1):76. PubMed ID: 32665033
[TBL] [Abstract][Full Text] [Related]
30. Comparison of tumor-infiltrating lymphocytes between primary and metastatic tumors in breast cancer patients.
Ogiya R; Niikura N; Kumaki N; Bianchini G; Kitano S; Iwamoto T; Hayashi N; Yokoyama K; Oshitanai R; Terao M; Morioka T; Tsuda B; Okamura T; Saito Y; Suzuki Y; Tokuda Y
Cancer Sci; 2016 Dec; 107(12):1730-1735. PubMed ID: 27727484
[TBL] [Abstract][Full Text] [Related]
31. Emodin Inhibits Breast Cancer Growth by Blocking the Tumor-Promoting Feedforward Loop between Cancer Cells and Macrophages.
Iwanowycz S; Wang J; Hodge J; Wang Y; Yu F; Fan D
Mol Cancer Ther; 2016 Aug; 15(8):1931-42. PubMed ID: 27196773
[TBL] [Abstract][Full Text] [Related]
32. Long non-coding RNA NKILA inhibited angiogenesis of breast cancer through NF-κB/IL-6 signaling pathway.
Luo LH; Rao L; Luo LF; Chen K; Ran RZ; Liu XL
Microvasc Res; 2020 May; 129():103968. PubMed ID: 31862380
[TBL] [Abstract][Full Text] [Related]
33. Bioactive lysolipids in cancer and angiogenesis.
Hisano Y; Hla T
Pharmacol Ther; 2019 Jan; 193():91-98. PubMed ID: 30048709
[TBL] [Abstract][Full Text] [Related]
34. Doxycycline attenuates breast cancer related inflammation by decreasing plasma lysophosphatidate concentrations and inhibiting NF-κB activation.
Tang X; Wang X; Zhao YY; Curtis JM; Brindley DN
Mol Cancer; 2017 Feb; 16(1):36. PubMed ID: 28178994
[TBL] [Abstract][Full Text] [Related]
35. Mesenchymal stem cells and macrophages interact through IL-6 to promote inflammatory breast cancer in pre-clinical models.
Wolfe AR; Trenton NJ; Debeb BG; Larson R; Ruffell B; Chu K; Hittelman W; Diehl M; Reuben JM; Ueno NT; Woodward WA
Oncotarget; 2016 Dec; 7(50):82482-82492. PubMed ID: 27756885
[TBL] [Abstract][Full Text] [Related]
36. Sphingosine-1-phosphate promotes PDGF-dependent endothelial progenitor cell angiogenesis in human chondrosarcoma cells.
Wang CQ; Lin CY; Huang YL; Wang SW; Wang Y; Huang BF; Lai YW; Weng SL; Fong YC; Tang CH; Lv Z
Aging (Albany NY); 2019 Dec; 11(23):11040-11053. PubMed ID: 31809267
[TBL] [Abstract][Full Text] [Related]
37. Frequency of Immune Cell Subtypes in Peripheral Blood Correlates With Outcome for Patients With Metastatic Breast Cancer Treated With High-Dose Chemotherapy.
Lafrenie RM; Speigl L; Buckner CA; Pawelec G; Conlon MS; Shipp C
Clin Breast Cancer; 2019 Dec; 19(6):433-442. PubMed ID: 31383605
[TBL] [Abstract][Full Text] [Related]
38. Expression of epithelial-mesenchymal transition driver brachyury and status of tumor-infiltrating CD8+ and FOXP3+ lymphocytes in predicting treatment responses to neoadjuvant chemotherapy of breast cancer.
Lee KH; Kim EY; Park YL; Do SI; Chae SW; Park CH
Tumour Biol; 2017 Jun; 39(6):1010428317710575. PubMed ID: 28621227
[TBL] [Abstract][Full Text] [Related]
39. Transforming growth factor-induced gene TGFBI is correlated with the prognosis and immune infiltrations of breast cancer.
Wang H; Wang X; Xu L
World J Surg Oncol; 2024 Jan; 22(1):22. PubMed ID: 38245723
[TBL] [Abstract][Full Text] [Related]
40. A novel five-gene score to predict complete pathological response to neoadjuvant chemotherapy in ER-positive/HER2-negative breast cancer.
Oshi M; Gandhi S; Angarita FA; Kim TH; Tokumaru Y; Yan L; Matsuyama R; Endo I; Takabe K
Am J Cancer Res; 2021; 11(7):3611-3627. PubMed ID: 34354863
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
